Modernizing Good Clinical Practice: Key Insights and Impact of ICH E6(R3) Guideline
Abstract
An updated version of the Good Clinical Practice Guideline, E6(R3), has been made available by the International Council for Harmonization. This guideline places a strong emphasis on a more adaptable, risk-based method of trial supervision. Quality by Design (QbD) adoption, attention to Critical-to-Quality (CtQ) factors, participant safety enhancement, adoption of Digital Health Technologies (DHTs), decentralized trials, elucidation of sponsor, investigator roles and responsibilities are some of the major effects. The implementation of risk-based monitoring, updating SOPs, quality systems, bolstering data governance with technologies like audit trails and metadata are examples of operational impacts. These updates seek to minimize needless burden, safeguard the rights, safety, and well-being of trial participants, promote innovation in trial design and conduct, and assure data reliability.
Conclusion: This review article provides a comprehensive review of the major revisions to the GCP guidelines, offering insights into the E6(R3) framework, its key impacts, and the essential takeaways for modern clinical trial conduct.
Downloads
References
https://database.ich.org/sites/default/files/ICH_E6%28R3%29_Step4_FinalGuideline_2025_0106.pdf
2. ICH. E6(R2) Good Clinical Practice Guideline [Internet]. Geneva: ICH; 2016 [cited 2023 Jan 20]. Available from: https://database.ich.org/sites/default/files/E6_R2_Addendum.pdf
3. ICH. E6(R3) Good Clinical Practice Guideline Draft Version [Internet]. Geneva: ICH; 2023 [cited 2025 Jan 02]. Available from:
https://database.ich.org/sites/default/files/ICH_E6%28R3%29_DraftGuideline_2023_0519.pdf
4. ICH. E6(R3) Presentation on Good Clinical Practice [Internet]. Genva: ICH; 2025 [cited 2025 Aug 09]. Available from:
https://database.ich.org/sites/default/files/ICH_E6%28R3%29_Step%204_Presentation_2025_0123.pdf
5. ICH. E8(R1) General Considerations for Clinical Studies Guideline [Internet]. Geneva: ICH; 2022 [cited 2025 Aug 09]. Available from:
https://database.ich.org/sites/default/files/ICH_E8-R1_Guideline_Step4_2021_1006.pdf
6. Bhatt A. The revamped Good Clinical Practice E6(R3) guideline: Profound changes in principles and Practice!. Perspectives in Clinical Research [Internet]. India: Medknow; 2023 [cited 2025 Aug 09]. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC10679570/
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The International Journal of Drug Regulatory affairs require a formal written transfer of copyright from the author(s) for each article published. We therefore ask you to complete and return this form, retaining a copy for your records. Your cooperation is essential and appreciated. Any delay will result in a delay in publication.
I/we have read and agree with the terms and conditions stated Page 2 of this agreement and I/we hereby confirm the transfer of all copyrights in and relating to the above-named manuscript, in all forms and media, now or hereafter known, to the International Journal of Drug Regulatory affairs, effective from the date stated below. I/we acknowledge that the IJDRA is relying on this agreement in publishing the above-named manuscript. However, this agreement will be null and void if the manuscript is not published in the IJDRA.
Download link for COPYRIGHT FORM
